Clinical Trial Update: Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of ciclesonide administered with or without different spacers in patients aged 12 to 75 with asthma. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Alvesco (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED